IS IV THERAPY SAFE
Research studies have further explored its mechanism of action
The HCG program has 4 Phases The main goal of our group is to aggressively help you lose weight in the fastest method imaginable using hCG, a VLCD (very low-calorie diet), and an understanding of calories, fat, and metabolism
The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV
AOD 9604 vs Tirzepatide: Summarizing Key Differences Fat Loss Mechanism AOD 9604: Direct lipolysis stimulation and lipogenesis inhibition Tirzepatide: Caloric deficit from appetite suppression plus metabolic optimization Appetite Impact AOD 9604: No significant effect Tirzepatide: Powerful suppression via GLP-1/GIP pathways Metabolic Pathway AOD 9604: Beta-3 adrenergic receptor activation (and likely additional pathways) in adipose tissue Tirzepatide: GLP-1 and GIP receptor agonism affecting glucose metabolism and insulin secretion Evidence Base AOD 9604: Primarily animal studies with mechanistic data Tirzepatide: Extensive human clinical trials with proven outcomes Timeline AOD 9604: 4-6+ weeks for visible effects in animal models Tirzepatide: Progressive weight loss documented across clinical trial periods over as long as 72 weeks How to Choose Between AOD 9604 and Tirzepatide Stop looking for the best peptide and start asking which mechanism addresses YOUR specific physiology
the inventors also surprisingly found inhibitory activity with certain embodiments of the invention where R 1 is methyl with dual positional substitutions (see e.g., compounds 2j, 2m, 2k, and 2l, Table 2)
